Antithrombotic agents and thromboembolic disease

被引：12

作者：

Ewenstein, BM

机构：

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1997年 / 337卷 / 19期

关键词：

D O I：

10.1056/NEJM199711063371909

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1383 / 1384

页数：2

共 16 条

[1]

[Anonymous], 1994, Hemostasis and thrombosis: basic principle and clinical practice

[2] TREATMENT WITH BIVALIRUDIN (HIRULOG) AS COMPARED WITH HEPARIN DURING CORONARY ANGIOPLASTY FOR UNSTABLE OR POSTINFARCTION ANGINA [J].

BITTL, JA ;

STRONY, J ;

BRINKER, JA ;

AHMED, WH ;

MECKEL, CR ;

CHAITMAN, BR ;

MARAGANORE, J ;

DEUTSCH, E ;

ADELMAN, B .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (12) :764-769

[3] PREVENTION OF VENOUS THROMBOEMBOLISM [J].

CLAGETT, GP ;

ANDERSON, FA ;

HEIT, J ;

LEVINE, MN ;

WHEELER, HB .

CHEST, 1995, 108 (04) :S312-S334

[4] REDUCTION IN FATAL PULMONARY-EMBOLISM AND VENOUS THROMBOSIS BY PERIOPERATIVE ADMINISTRATION OF SUBCUTANEOUS HEPARIN - OVERVIEW OF RESULTS OF RANDOMIZED TRIALS IN GENERAL, ORTHOPEDIC, AND UROLOGIC SURGERY [J].

COLLINS, R ;

SCRIMGEOUR, A ;

YUSUF, S ;

PETO, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (18) :1162-1173

[5]

DECHAVANNE M, 1989, HAEMOSTASIS, V19, P5

[6] Prevention of thromboembolism with use of recombinant hirudin - Results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement [J].

Eriksson, BI ;

Ekman, S ;

Lindbratt, S ;

Baur, M ;

Bach, D ;

Torholm, C ;

Kalebo, P ;

Close, P .

JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1997, 79A (03) :326-333

[7] A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement [J].

Eriksson, BI ;

WilleJorgensen, P ;

Kalebo, P ;

Mouret, P ;

Rosencher, N ;

Bosch, P ;

Baur, M ;

Ekman, S ;

Bach, D ;

Lindbratt, S ;

Close, P .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (19) :1329-1335

[8] Prevention of deep-vein thrombosis after total hip replacement: Direct thrombin inhibition with recombinant hirudin, CGP 39393 [J].

Eriksson, BI ;

Ekman, S ;

Kalebo, P ;

Zachrisson, B ;

Bach, D ;

Close, P .

LANCET, 1996, 347 (9002) :635-639

[9] A COMPARISON OF SUBCUTANEOUS LOW-MOLECULAR-WEIGHT HEPARIN WITH WARFARIN SODIUM FOR PROPHYLAXIS AGAINST DEEP-VEIN THROMBOSIS AFTER HIP OR KNEE IMPLANTATION [J].

HULL, R ;

RASKOB, G ;

PINEO, G ;

ROSENBLOOM, D ;

EVANS, W ;

MALLORY, T ;

ANQUIST, K ;

SMITH, F ;

HUGHES, G ;

GREEN, D ;

ELLIOTT, CG ;

PANJU, A ;

BRANT, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (19) :1370-1376

[10] A METAANALYSIS OF METHODS TO PREVENT VENOUS THROMBOEMBOLISM FOLLOWING TOTAL HIP-REPLACEMENT [J].

IMPERIALE, TF ;

SPEROFF, T .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (22) :1780-1785

← 1 2 →